Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. - Wikidata - wikimedia - TriplyDB

Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features.

Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features.

http://www.wikidata.org/entity/Q30463819

about

Neuroinflammation and psychiatric illness Ketamine and other glutamate receptor modulators for depression in adults The neuroimmunology of schizophrenia Glutamatergic autoencephalitides: an emerging field Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis Profiling neuronal ion channelopathies with non-invasive brain imaging and dynamic causal models: Case studies of single gene mutations The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies.Generating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction data Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate.Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders.Antibodies to GABAA receptor α1 and γ2 subunits: clinical and serologic characterization.Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: an integrated DTI study.Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study.Autoantibodies against the N-Methyl-d-Aspartate Receptor Subunit NR1: Untangling Apparent Inconsistencies for Clinical Practice.Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.Absence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis.Exploring the presence of narcolepsy in patients with schizophrenia.Autoimmune limbic encephalitis presenting as relapsing psychosis.Autoantibodies and the immune hypothesis in psychotic brain diseases: challenges and perspectives.Electroconvulsive therapy and/or plasmapheresis in autoimmune encephalitis?The role of NMDAR antibody in the etiopathogenesis of schizophrenia.N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: case reports and methods for detection.HLA associations in schizophrenia: are we re-discovering the wheel?Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implications.Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry.Anti N-methyl-D-aspartate receptor encephalitis: a game-changer?NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between Toxoplasma gondii and N-Methyl-d-Aspartate Receptors As a Potential Mechanistic Link.Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii.Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China.Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.[Anti-NR1 antibodies in anti-N-methyl-D-aspartate receptor encephalitis and schizophrenia].Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients.Anti-NMDA-R encephalitis: follow-up of 24 months.Comparisons between Psychiatric Symptoms of Patients with Anti-NMDAR Encephalitis and New-Onset Psychiatric Patients.Brain-relevant antibodies in first-episode psychosis: a matched case-control study.Antibodies attacking the brain: Is it time for a paradigm shift in psychiatric practice and service models?A 16-year-old girl with anti-NMDA-receptor encephalitis and family history of psychotic disorders.

P2860

Q21245244-08CD2C5D-4ED7-466D-BBAB-2BC5B6F2E14C Q24186746-5D214DF4-E7DB-4BC4-81BD-F5B7B79BE5DA Q26859392-CBECD534-4654-48C1-8594-E7741517A2DD Q26992294-F8FE77A4-DAC5-4E72-8F44-29D84EF1F85B Q28303840-B2DCE1AC-44B9-4D2A-B5B6-B217BAB7943A Q30394990-0B59C05A-D4AC-4844-A55B-22C50F38FC11 Q33577793-3B200713-9584-49FA-B56C-B2530563F98B Q33718785-B8DFDD94-2975-48F0-8AF7-68991FE57940 Q34068000-4651D8E3-F837-4196-AA01-7733A47E7F9C Q34126143-6A2D9FE2-914A-4466-90E5-9725DD8809F0 Q34460610-473E422C-D87C-46FA-9846-7D28BFE9EDA8 Q34669114-01279362-E704-47A6-B2C5-57D14171049B Q34778126-88C4CFDA-9C06-49FD-AA71-86D678850FA4 Q36071538-7FEE3178-B943-4578-A1EE-1793A543B0B6 Q36309804-24CB85E1-0CF0-4414-A647-4A628D2A5E43 Q36634134-5B25B127-ECA7-4D07-A140-B76DCD7C5366 Q36865000-98F99250-3167-4CD2-9253-59CA0CB011CD Q36955561-F89B6444-F4A1-4A03-9F25-BABA7586B5FE Q37144967-5E7CE66B-FD36-4377-B63F-0AA4D78866D2 Q37154797-006F90D6-1D16-4297-B447-E50919D79300 Q37172747-0AE07933-D9DE-4DD6-968E-B947FC2EC0FF Q37265886-CACECFC5-2E22-4FD4-A1B2-7DB5E502A36F Q37641467-5A689999-E66D-458C-BAE1-346E8A29A3EF Q38154240-865F4DF4-44EE-49E3-A14B-07BBDCBB3815 Q38365916-64FE8209-E1A3-4792-B623-C86851AE227B Q38530339-23EE4CEE-1211-467B-AFF4-4A8C94E9E139 Q38819747-19ABF3BD-552D-43C5-914C-DC12B2835ED3 Q38821460-11308F2C-60A7-4DC4-9C50-6563E1695325 Q40271254-684409F8-C41C-42BD-8D89-E0A598AA8793 Q40758347-CAD61A4C-F0C3-45CC-9E34-DBC48EE87A75 Q41127496-C9AE9065-EA2D-4E60-8083-41301EA1A486 Q42272536-29C382A2-FA94-49A9-8BBD-196E0038F150 Q44533955-FDBD3BF0-19CD-40AC-8B54-69E39FABFBA9 Q47116610-21D530A1-C750-4F88-A6C6-2C8D4A6F9BCF Q47139247-57A2C89B-5D58-49B7-B1B2-41C235C4F971 Q47168830-44CB7574-C5AE-42AE-8F4F-1F080C265F54 Q47590126-E179F61F-2A57-4A96-8198-EC17DA1EE2CE Q47787761-5488BE45-1A73-4CC6-AD36-7AA1ACBDB4FB Q48906895-B47B6C58-00FC-4544-9881-AB966C317549 Q50310741-298E415D-2C36-478F-BD99-ADA7F0B03E0C

P2860

Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features.

http://www.wikidata.org/entity/Q30463819

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Anti-NMDA-receptor antibody de ...... lepsy with psychotic features.

@ast

Anti-NMDA-receptor antibody de ...... lepsy with psychotic features.

@en

type

label

Anti-NMDA-receptor antibody de ...... lepsy with psychotic features.

@ast

Anti-NMDA-receptor antibody de ...... lepsy with psychotic features.

@en

prefLabel

Anti-NMDA-receptor antibody de ...... lepsy with psychotic features.

@ast

Anti-NMDA-receptor antibody de ...... lepsy with psychotic features.

@en

P1433

Q30463819-B87D04E5-38C3-44DD-81C3-118C27EBA643

P1476

Q30463819-0C897969-4B7A-4B6C-AC2F-5DE7ED0F5EF6

P2093

Q30463819-0F335FAC-28DD-4A59-89DE-6F9FEC66F2DE

Q30463819-2910EC9D-E992-4AF3-A784-CAB30814AE47

Q30463819-7B5026F5-0F12-47CF-85AA-18C0CF731633

Q30463819-8C2DA803-9116-4331-BB46-7A96AE900C03

Q30463819-8E2437CE-1369-4E87-805C-813B34963959

Q30463819-9ACA7984-7ABA-4752-BABC-6F8DF4C50191

Q30463819-A065FFD7-CA1F-43E4-B735-ECF0EEEE17D0

Q30463819-B0C8E581-CE8F-4B63-9315-1471CC203CFC

Q30463819-DCE3D38F-422D-46B4-A53E-F8748533B427

Q30463819-ECD189AA-93A8-4555-930F-572C23C36EEB

P2860

Q30463819-14B7BCF8-6922-4FA8-9D7E-05F82834E184

Q30463819-182E0C3B-8C99-4C9E-BCC2-E1B9D1CD040C

Q30463819-32855E50-BF33-4F4F-BA02-A2774AB8E22A

Q30463819-35905F43-F123-46EF-96FF-66B7BD77C322

Q30463819-3B9333F0-22BE-4368-8E52-70393E8D9259

Q30463819-3D1D5B4C-4F13-4E3B-BD9D-AB29EAE4C210

Q30463819-40AB5195-8A29-4BDD-BA77-502C41441F03

Q30463819-47E69EBD-8A76-4F1A-8845-AEFB28D66B35

Q30463819-485A2FAB-241A-430F-AA15-28F50A13EDAA

Q30463819-55503DAF-DDFC-4E85-B356-62969472C001

P2888

Q30463819-76D70375-521A-4E81-8A1C-6CF36CF061E0

P304

Q30463819-6881B70E-DFAE-43FA-9C97-C034725DAC86

P31

Q30463819-0CB16496-AD4F-466D-B950-A12E09E15920

P356

Q30463819-E266F85C-B1CA-493B-8550-705E2B92E788

P478

Q30463819-89FD0A96-D157-41B0-BB3A-86FA6CD8758E

P577

Q30463819-1E935031-009A-4BDE-8F14-11E301669A7A

P6179

Q30463819-D49CCD3F-F380-4024-AA28-8145CA4A6E7B

P698

Q30463819-73BA3236-C63E-4355-80AE-3E057C48CA38

P921

Q30463819-56130849-E681-43A2-BE6C-45B2D5D599AA

Q30463819-59BFF860-AEF1-4F56-9EE3-69A3C2F3F98F

Q30463819-621838DB-B1A9-47F9-97D2-C38AC01C253B

Q30463819-E3274E87-26A8-4FBC-903F-05265CD6A1D4

P932

Q30463819-82BEE3FA-B644-432A-BCAB-5924CACACB1B

P356

1471-244X-12-37

P1433

P1476

Anti-NMDA-receptor antibody de ...... lepsy with psychotic features.

@en

P2093

Akane Mori

http://www.w3.org/2001/XMLSchema#string

Jun Tokunaga

http://www.w3.org/2001/XMLSchema#string

Keiko Tanaka

http://www.w3.org/2001/XMLSchema#string

Ko Tsutsui

http://www.w3.org/2001/XMLSchema#string

Seiji Nishino

http://www.w3.org/2001/XMLSchema#string

Shuken Boku

http://www.w3.org/2001/XMLSchema#string

Takashi Kanbayashi

http://www.w3.org/2001/XMLSchema#string

Tetsuo Shimizu

http://www.w3.org/2001/XMLSchema#string

Wakako Ito

http://www.w3.org/2001/XMLSchema#string

Yasuo Hishikawa

http://www.w3.org/2001/XMLSchema#string

P2860

Common variants conferring risk of schizophrenia

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

A patient with encephalitis associated with NMDA receptor antibodies

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

Disease-relevant autoantibodies in first episode schizophrenia

Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?

Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring

P2888

1471-244x-12-37

P304

37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-244X-12-37

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1011002625

http://www.w3.org/2001/XMLSchema#string

P698

22569157

http://www.w3.org/2001/XMLSchema#string

P921

P932

3436772

http://www.w3.org/2001/XMLSchema#string